Nicotinell Nicotine Replacement Therapy

Nicotinell is a globally recognized brand in the nicotine replacement therapy (NRT) sector, offering products such as patches, gums, and lozenges designed to assist individuals in smoking cessation. Originally developed with a strong focus on pharmaceutical innovation, the brand has built a reputation for providing reliable clinical solutions to nicotine dependence.

Today, Nicotinell is part of the Haleon portfolio. Following a major corporate demerger from GSK (GlaxoSmithKline) in 2022, Haleon emerged as an independent consumer healthcare giant. The manufacturing of Nicotinell products occurs in multiple high-standard pharmaceutical facilities across Europe and other regions, ensuring global distribution through pharmacies and healthcare providers.